Previous close | 2.8700 |
Open | 3.1200 |
Bid | 2.3600 |
Ask | 2.4600 |
Strike | 27.00 |
Expiry date | 2024-10-18 |
Day's range | 2.8000 - 3.1200 |
Contract range | N/A |
Volume | |
Open interest | 838 |
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.